Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Innovaderm, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Health
Other Health
General Health
Clinical Trials
Research
Science
Pharmaceutical
Innovaderm Research Inc.

More Like This

Business Wire logo

Innovaderm, Recognized by Clinical Leaders CRO Leadership Awards for the 4th Consecutive Year

Business Wire logo

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO

Business Wire logo

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

Business Wire logo

Specialist CRO Welcomes Dr Juan Gabriel Ovalles Bonilla as Medical Rheumatology Lead

PR Newswire associated0

Alphyn to Present Poster on Zabalafin Hydrogel Clinical Results at European Academy of Dermatology and Venereology Congress 2024

Business Wire logo

Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting

Business Wire logo

Innovaderm Research, a Dual Focus CRO, Appoints Jeff Smith as New CEO

Business Wire logo

New Data from Incyte’s Growing Dermatology Portfolio to be Presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us